These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20388407)

  • 1. [Role of Cripto-1 protein in development and target therapy of breast cancer].
    Lei T; Guo XJ; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):66-8. PubMed ID: 20388407
    [No Abstract]   [Full Text] [Related]  

  • 2. Cripto as a target for cancer immunotherapy.
    Hu XF; Xing PX
    Expert Opin Ther Targets; 2005 Apr; 9(2):383-94. PubMed ID: 15934922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cripto monoclonal antibodies.
    Hu XF; Xing PX
    Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the cripto (EGF-CFC) family in embryogenesis and cancer.
    Bianco C; Normanno N; Salomon DS; Ciardiello F
    Growth Factors; 2004 Sep; 22(3):133-9. PubMed ID: 15518236
    [No Abstract]   [Full Text] [Related]  

  • 6. Cripto: a novel target for antibody-based cancer immunotherapy.
    Xing PX; Hu XF; Pietersz GA; Hosick HL; McKenzie IF
    Cancer Res; 2004 Jun; 64(11):4018-23. PubMed ID: 15173016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the embryonic gene Cripto-1 in cancer and beyond.
    Bianco C; Salomon DS
    Expert Opin Ther Pat; 2010 Dec; 20(12):1739-49. PubMed ID: 21073352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues.
    Panico L; D'Antonio A; Salvatore G; Mezza E; Tortora G; De Laurentiis M; De Placido S; Giordano T; Merino M; Salomon DS; Mullick WJ; Pettinato G; Schnitt SJ; Bianco AR; Ciardiello F
    Int J Cancer; 1996 Jan; 65(1):51-6. PubMed ID: 8543395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.
    Kenney NJ; Adkins HB; Sanicola M
    J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):133-44. PubMed ID: 15300009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.
    Strizzi L; Postovit LM; Margaryan NV; Seftor EA; Abbott DE; Seftor RE; Salomon DS; Hendrix MJ
    Breast Dis; 2008; 29():91-103. PubMed ID: 19029628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human cripto-1 in tumor angiogenesis.
    Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
    J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Cripto-1 as a target for a cancer vaccine: WO2008040759.
    Bianco C; Salomon DS
    Expert Opin Ther Pat; 2009 Feb; 19(2):141-4. PubMed ID: 19441915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Cripto-1 in stem cell maintenance and malignant progression.
    Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
    Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.
    Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C
    Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
    Miharada K; Karlsson G; Rehn M; Rörby E; Siva K; Cammenga J; Karlsson S
    Ann N Y Acad Sci; 2012 Aug; 1266():55-62. PubMed ID: 22901256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto-1: an extracellular protein - connecting the sequestered biological dots.
    Klauzinska M; Bertolette D; Tippireddy S; Strizzi L; Gray PC; Gonzales M; Duroux M; Ruvo M; Wechselberger C; Castro NP; Rangel MC; Focà A; Sandomenico A; Hendrix MJ; Salomon D; Cuttitta F
    Connect Tissue Res; 2015; 56(5):364-80. PubMed ID: 26327334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.
    Normanno N; De Luca A; Bianco C; Maiello MR; Carriero MV; Rehman A; Wechselberger C; Arra C; Strizzi L; Sanicola M; Salomon DS
    J Cell Physiol; 2004 Jan; 198(1):31-9. PubMed ID: 14584041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cripto-1 as a novel therapeutic target for triple negative breast cancer.
    Castro NP; Fedorova-Abrams ND; Merchant AS; Rangel MC; Nagaoka T; Karasawa H; Klauzinska M; Hewitt SM; Biswas K; Sharan SK; Salomon DS
    Oncotarget; 2015 May; 6(14):11910-29. PubMed ID: 26059540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells.
    Arnouk H; Yum G; Shah D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.